178 related articles for article (PubMed ID: 37328332)
21. Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies.
Marzano L; Colussi G; Sechi LA; Catena C
Am J Hypertens; 2015 Mar; 28(3):312-8. PubMed ID: 25336498
[TBL] [Abstract][Full Text] [Related]
22. Primary Aldosteronism: Present and Future.
Funder JW
Vitam Horm; 2019; 109():285-302. PubMed ID: 30678860
[TBL] [Abstract][Full Text] [Related]
23. Approach to the surgical management of primary aldosteronism.
Iacobone M; Citton M; Viel G; Rossi GP; Nitti D
Gland Surg; 2015 Feb; 4(1):69-81. PubMed ID: 25713782
[TBL] [Abstract][Full Text] [Related]
24. Benefits of Surgical Over Medical Treatment for Unilateral Primary Aldosteronism.
Ahmed S; Hundemer GL
Front Endocrinol (Lausanne); 2022; 13():861581. PubMed ID: 35557845
[TBL] [Abstract][Full Text] [Related]
25. Primary aldosteronism: renaissance of a syndrome.
Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
[TBL] [Abstract][Full Text] [Related]
26. Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.
Carey RM
Curr Cardiol Rep; 2016 Oct; 18(10):97. PubMed ID: 27566330
[TBL] [Abstract][Full Text] [Related]
27. 2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism.
Ha J; Park JH; Kim KJ; Kim JH; Jung KY; Lee J; Choi JH; Lee SH; Hong N; Lim JS; Park BK; Kim JH; Jung KC; Cho J; Kim MK; Chung CH; ;
Endocrinol Metab (Seoul); 2023 Dec; 38(6):597-618. PubMed ID: 37828708
[TBL] [Abstract][Full Text] [Related]
28. Prediction of successful outcome in patients with primary aldosteronism.
Moo TA; Zarnegar R; Duh QY
Curr Treat Options Oncol; 2007 Aug; 8(4):314-21. PubMed ID: 18058076
[TBL] [Abstract][Full Text] [Related]
29. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
Amar L; Plouin PF; Steichen O
Orphanet J Rare Dis; 2010 May; 5():9. PubMed ID: 20482833
[TBL] [Abstract][Full Text] [Related]
30. Case detection and diagnosis of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism.
Wu VC; Hu YH; Er LK; Yen RF; Chang CH; Chang YL; Lu CC; Chang CC; Lin JH; Lin YH; Wang TD; Wang CY; Tu ST; Jeff Chueh SC; Chang CC; Tseng FY; Wu KD;
J Formos Med Assoc; 2017 Dec; 116(12):993-1005. PubMed ID: 28735660
[TBL] [Abstract][Full Text] [Related]
31. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Amar L; Baguet JP; Bardet S; Chaffanjon P; Chamontin B; Douillard C; Durieux P; Girerd X; Gosse P; Hernigou A; Herpin D; Houillier P; Jeunemaitre X; Joffre F; Kraimps JL; Lefebvre H; Ménégaux F; Mounier-Véhier C; Nussberger J; Pagny JY; Pechère A; Plouin PF; Reznik Y; Steichen O; Tabarin A; Zennaro MC; Zinzindohoue F; Chabre O
Ann Endocrinol (Paris); 2016 Jul; 77(3):179-86. PubMed ID: 27315757
[TBL] [Abstract][Full Text] [Related]
32. Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery?
Sechi LA; Colussi GL; Novello M; Uzzau A; Catena C
Horm Metab Res; 2015 Dec; 47(13):1000-6. PubMed ID: 26667803
[TBL] [Abstract][Full Text] [Related]
33. [Hyperaldosteronism].
Scholl UI
Internist (Berl); 2021 Mar; 62(3):245-251. PubMed ID: 33599784
[TBL] [Abstract][Full Text] [Related]
34. Impact of Primary Aldosteronism in Resistant Hypertension.
Stavropoulos K; Imprialos KP; Patoulias D; Katsimardou A; Doumas M
Curr Hypertens Rep; 2022 Aug; 24(8):285-294. PubMed ID: 35445928
[TBL] [Abstract][Full Text] [Related]
35. [Primary aldosteronism: The Mayo Clinic approach].
Young W; Ladygina DO; Balutina OV; Beltsevich DG
Ter Arkh; 2020 Nov; 92(10):83-87. PubMed ID: 33346484
[TBL] [Abstract][Full Text] [Related]
36. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of drug-based and surgical treatments for primary aldosteronism.
Steichen O; Lorthioir A; Zinzindohoue F; Plouin PF; Amar L
Adv Chronic Kidney Dis; 2015 May; 22(3):196-203. PubMed ID: 25908468
[TBL] [Abstract][Full Text] [Related]
38. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
[TBL] [Abstract][Full Text] [Related]
39. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.
Naruse M; Katabami T; Shibata H; Sone M; Takahashi K; Tanabe A; Izawa S; Ichijo T; Otsuki M; Omura M; Ogawa Y; Oki Y; Kurihara I; Kobayashi H; Sakamoto R; Satoh F; Takeda Y; Tanaka T; Tamura K; Tsuiki M; Hashimoto S; Hasegawa T; Yoshimoto T; Yoneda T; Yamamoto K; Rakugi H; Wada N; Saiki A; Ohno Y; Haze T
Endocr J; 2022 Apr; 69(4):327-359. PubMed ID: 35418526
[TBL] [Abstract][Full Text] [Related]
40. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
Hypertension; 2018 Sep; 72(3):658-666. PubMed ID: 29987110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
